Medindia

X

Publicis Groupe Strengthens its Leadership in Digital and Integrated Healthcare Communications in Italy

Friday, October 12, 2007 General News J E 4
Advertisement
PARIS, October 11 Publicis Groupe (NYSE: PUB)has announced today two key acquisitions designed to reinforce its offer indigital and healthcare communication services. These targeted acquisitionsaim at strengthening Publicis Groupe's leadership in both areas on theItalian market.

- Healthware SpA, (Salerno), a highly innovative agency, specialized indigital communications programs for the healthcare industry,

- Multimedia Healthcare Communication S.r.l. (Milan), leading independentmarket development and public relations agency.

These two acquisitions consolidate the position of Publicis HealthcareCommunications Group (PHCG), as a leader in healthcare communications, bothglobally and in Italy. PHCG now employs 90 healthcare communications expertsin Italy, through specialized units covering the different market segments:Saatchi & Saatchi Healthcare, Saatchi & Saatchi Consumer Health, Medicus,Discovery and, now, Healthware and Multimedia Healthcare Communication.

Healthware SpA was founded in 1996, and delivers a complete range ofintegrated digital communication services to clients across European and U.S.markets. Healthware's innovative healthcare communication offer includeshealthcare portals, search engine marketing, health informatics, learningmanagement systems, CRM programs and e-detailing. Combining innovativetechnological solutions with an integrated marketing approach, Healthwareprovides its clients with responses adapted to meeting increasingly complexclient needs. The agency has a long history of fruitful collaboration withPHCG, and the complementary nature of its services has already contributed tonumerous successes.

Multimedia Healthcare Communication is distinguished by its singularfocus on the healthcare market and its ability to integrate medicaleducation, event management and media relations. The company's specializedknowledge and experience in healthcare provides clients with a competitiveedge in meeting marketing objectives. Multimedia services a wide array ofleading clients including Procter & Gamble, AstraZeneca and sanofi-aventis.

Both Healthware and Multimedia will remain separate units with their ownidentities within PHCG. Healthware will continue to be led by RobertoAscione, and Multimedia Healthcare Communication will be led by Simona Bossi.Both will now report to Leonardo Vinci, President of PHCG Italy.

"Healthware and Multimedia are both very synergistic acquisitions forPHCG. Healthware has proven to be a great strategic partner and a wealth ofknowledge in digital, as we've seen in their collaboration with Saatchi &Saatchi Italy" said Nick Colucci, Chief Executive Officer of PHCG."Multimedia brings an unparalleled communications advantage to our PHCG Italyoperations, allowing us to pool together our communication channel expertisewith our knowledge of healthcare professionals and products, to optimize ourclients' communication programs."

About Healthware SpA

Leading performer in innovation and technology, Healthware is an e-healthcompany specialized in the healthcare communications business with a stronge-health and information technology focus. Founded in Italy in 1996,Healthware employs nearly 50 professionals. Mixing research and developmentwith consulting services and software production, Healthware developsintegrated projects as well as products and solutions aiming to improvecommunication on healthcare matters. Products cover a wide range of needsincluding: Electronic Health Record (EHR) and Clinical Information Systems;Health Networks, HCP Community, Telemedicine; Solutions for interactivecommunication, e-business, e-marketing, e-detailing, e-CRM, CME ande-learning, e-science, on-line disease management; Web-sites, portals, aswell as Internet/Intranet solutions for Hospitals, Scientific Societies andHealth Institutions, as well as CME and Training.

We
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Genmab Amends HuMax-CD4 Pivotal Study in CTCL
S
ADVENTRX Announces Completion of Patient Enrollmen...